Heart failure (HF) and chronic obstructive pulmonary disease (COPD) frequently coexist and are associated with substantial morbidity, mortality, and healthcare utilization. Accumulating evidence suggests that these conditions also share biological mechanisms that contribute to disease progression. However, although num...
L. Corneanu, O. Petriș, V. Șorodoc et al.· Biomedicine & pharmacotherap...· 0 citations
While current evidence supports its association with incident CVD, atherosclerotic burden, and adverse outcomes, further prospective, multiethnic studies are needed to define optimal thresholds, clarify its role alongside existing risk models, and determine whether TyG-guided strategies can improve clinical outcomes.
M. Cherska, Khrystyna Kukharchuk, A. Ceasovschih et al.· Lipids in Health and Disease· 0 citations
Current evidence on the pathophysiological mechanisms underlying CKM-related dyslipidaemia is examined and a practical framework for its assessment and management is provided to provide a practical framework for its assessment and management.
A. Ceasovschih, Y. Şener, M. Arici et al.· International Journal of Mol...· 0 citations
Patients presenting with decompensated heart failure had a more pronounced inflammatory profile than those with compensated heart failure, and higher CRP and SII levels were associated with in-hospital mortality in adjusted analyses.
Elena Cojocaru, V. Șorodoc, Cristian Cojocaru et al.· Metabolites· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.